An incident does not always mean that a product is defective. It means that something unusual has happened and needs to be properly assessed. The purpose of investigating an incident is to understand what happened, determine its possible impact, identify the underlying cause, and take appropriate action.
 |
| Understanding pharmaceutical incidents, investigation, documentation and prevention in Nepal. |
For pharmaceutical professionals working in Nepal, understanding incident management is useful in Quality Control (QC), Quality Assurance (QA), Production, Warehouse, Engineering and other GMP-related departments.
What Is an Incident in the Pharmaceutical Industry?
A pharmaceutical incident is an unexpected event that occurs during a pharmaceutical activity and may have an impact on product quality, safety, data integrity, equipment, personnel or regulatory compliance.
Incidents can occur at different stages of pharmaceutical operations.
For example:
- An HPLC stops during sample analysis.
- A balance suddenly gives an error.
- A production machine stops during processing.
- A warehouse temperature goes outside the approved range.
- A wrong material is found in the production area.
- A batch record contains an unexpected documentation error.
- An HVAC system stops working.
- A power failure interrupts a critical operation.
The event should be reported according to the company's approved SOP. The responsible team then determines whether it should be classified as an incident, deviation, equipment failure, laboratory event, or another quality-system event.
Incident vs Deviation in Pharmaceutical Industry
Incident and deviation are closely related, but they are not necessarily identical.
An incident generally refers to an unexpected event, while a deviation usually refers to an unplanned departure from an approved procedure, process, specification, or established requirement.
For example, an HPLC suddenly stopping during analysis can initially be considered an incident. If the event results in a departure from an approved analytical procedure, it may also require treatment under the company's deviation system.
The final classification should always follow the pharmaceutical company's approved quality procedures.
If you are studying deviation management, you can also read our detailed article on Deviation in Pharmaceutical Industry: Meaning, Types, Investigation and CAPA. It explains how deviations are investigated and how CAPA can be used to prevent recurrence.
Why Is Incident Management Important?
Ignoring an unexpected event can create a larger quality problem. Consider a temperature excursion in a pharmaceutical warehouse. If the event is not recorded, the company may not know whether stored materials were exposed to unsuitable conditions.
Proper incident management helps a company to:
- Detect problems at an early stage
- Protect product quality
- Assess possible risks
- Maintain reliable records
- Identify weaknesses in processes
- Prevent recurrence
- Improve GMP compliance
- Support effective CAPA
- Maintain confidence in laboratory and manufacturing data
Incident investigation also creates an opportunity for continuous improvement. A recurring problem may indicate that an existing procedure, equipment-maintenance program, training system, or monitoring process needs improvement.
Common Types of Pharmaceutical Incidents
Incidents can occur in almost every area of a pharmaceutical company.
Production Incidents
Production incidents happen during manufacturing activities.
Some examples are:
- Unexpected machine stoppage
- Power interruption
- Material spillage
- Incorrect machine setting
- Granulation interruption
- Compression-machine failure
- Unexpected process delay
The production team should record the event and inform the appropriate personnel. QA may then assess whether the incident could have affected the batch.
QC Laboratory Incidents
Quality Control laboratories handle instruments, samples, chemicals and analytical procedures, so unexpected events can occur during testing.
Examples include:
- HPLC malfunction
- UV spectrophotometer failure
- Analytical balance error
- Sample spillage
- Broken glassware
- Incorrect solution preparation
- Instrument communication failure
- Power interruption during analysis
The analyst should document the event and follow the relevant laboratory SOP.
For example, if an HPLC stops during testing, the analyst should preserve available chromatographic data and inform the responsible supervisor instead of simply deleting the sequence and starting again.
Related laboratory topics such as HPLC system suitability parameters, analytical calculations and laboratory practices can also help QC professionals understand why reliable instrument performance is important.
Warehouse and Storage Incidents
Warehouse incidents can involve materials, storage conditions and identification systems.
Examples include:
- Temperature excursion
- Wrong material location
- Damaged container
- Incorrect status label
- Material mix-up
- Expired material discovered in storage
- Incorrect material issued to production
When such an event occurs, potentially affected materials may need to be placed under appropriate status control until the assessment is completed.
Equipment-Related Incidents
Equipment problems are common sources of unexpected events.
Examples include:
- HPLC pump failure
- Dissolution apparatus malfunction
- Balance malfunction
- HVAC failure
- Compressed-air interruption
- Purified-water system problem
- Manufacturing equipment breakdown
The investigation should consider whether the equipment condition could have affected a product, process, sample or analytical result.
Documentation and Data-Integrity Incidents
Pharmaceutical companies depend heavily on accurate records.
An incident may involve:
- Missing information
- Incorrect entry
- Wrong date
- Missing signature
- Calculation mistake
- Damaged record
- Use of an incorrect document
- Recording information after the activity was completed
These events require careful assessment because documentation is part of the evidence showing what actually happened.
Understanding ALCOA and ALCOA+ principles in pharmaceutical data integrity is particularly useful when dealing with laboratory and manufacturing records.
How to Investigate a Pharmaceutical Incident
A good investigation should be logical and based on evidence.
1. Report the Incident
The person who notices the event should report it according to the applicable SOP.
The initial description should explain what happened, without making unsupported assumptions about the cause.
2. Take Immediate Action
Immediate action should prevent the situation from becoming worse.
Depending on the event, this may involve:
- Stopping the activity
- Informing the supervisor
- Informing QA
- Segregating affected material
- Protecting samples
- Preserving electronic data
- Stopping the use of defective equipment
3. Collect Evidence
The investigation team may review:
- Equipment logs
- Analytical data
- Batch records
- SOPs
- Training records
- Maintenance history
- Calibration records
- Environmental records
- Previous incidents
Good evidence makes the investigation stronger and reduces reliance on assumptions.
4. Assess the Impact
The team should determine whether the incident could affect:
- Product quality
- Patient safety
- Analytical results
- Data integrity
- Batch status
- GMP compliance
The impact should be supported by available information.
5. Find the Root Cause
The investigation should go beyond the immediate event.
Useful tools include:
- 5 Why analysis
- Fishbone/Ishikawa diagram
- Cause-and-effect analysis
- Trend review
- Equipment-history review
For example, if an instrument repeatedly stops, "instrument stopped" is the event—not necessarily the root cause. Further investigation may reveal a maintenance issue, component failure, software problem, environmental condition or another underlying reason.
6. Implement Corrective Action
Once the cause and impact are understood, appropriate action can be taken.
Depending on the situation, this may include equipment repair, procedure improvement, additional training, maintenance changes or process controls.
If the problem is systemic or recurring, CAPA may be required.
Example of an Incident in a Nepalese Pharmaceutical Company
The following is a hypothetical example for educational purposes and does not refer to a particular Nepalese company.
HPLC Failure During Assay Testing
Imagine that a QC analyst in a pharmaceutical company in Nepal is performing an assay test for a tablet batch.
Several injections have already been completed when the HPLC suddenly stops and displays an instrument error.
The analyst informs the QC supervisor and records the event.
The team then checks the chromatographic sequence, instrument log, system messages and maintenance history.
The investigation identifies a technical problem with the instrument pump.
The company evaluates which injections may have been affected and determines whether the available analytical data can be considered valid.
The instrument is repaired and the required performance checks are completed before further use.
If the investigation shows that similar failures have occurred repeatedly, the company may review its preventive-maintenance system and consider CAPA.
The important lesson is that the analyst should not simply repeat the analysis to obtain a passing result. The original event must first be understood.
Example of a Temperature Excursion in Nepal
Consider a hypothetical pharmaceutical warehouse in Nepal.
During a power interruption, the HVAC system stops. The temperature begins to rise beyond the approved storage range.
The temperature-monitoring system records the excursion.
The responsible employee reports the event, and the affected materials are identified.
The investigation considers:
- Duration of the excursion
- Maximum temperature
- Materials involved
- Approved storage requirements
- Temperature-monitoring records
- HVAC condition
- Power interruption
- Previous similar events
QA can then assess the available evidence and determine the appropriate disposition according to the company's procedure.
This example shows why continuous monitoring and accurate records are important in pharmaceutical storage.
Role of QA in Incident Management
QA provides important oversight during incident management.
Depending on the company's quality system, QA may:
- Review the incident report
- Assess potential quality impact
- Ensure an appropriate investigation
- Review root-cause analysis
- Review proposed CAPA
- Monitor recurring events
- Verify completion of actions
- Check investigation effectiveness
- Ensure proper documentation
However, QA does not investigate every incident alone. The investigation team may include personnel from QC, Production, Engineering, Warehouse, Microbiology or other relevant departments.
Common Mistakes During Incident Investigation
A few common mistakes can weaken an investigation.
Blaming an individual too quickly:
The person involved in the event is not automatically the root cause.
Ignoring evidence:
A conclusion should be supported by records, observations and other available information.
Unnecessary retesting:
Testing should not be repeated merely to obtain a desirable result.
Poor documentation:
Incomplete records can make it difficult to understand what actually happened.
Ignoring recurring problems:
Repeated incidents may indicate a deeper system weakness.
A good investigation focuses on improving the process rather than simply assigning blame.
Incident Trending and Continuous Improvement
Individual incidents are important, but reviewing them together can reveal useful trends.
For example, if a company notices that equipment-related incidents are increasing every month, it may review preventive maintenance, spare-parts availability, equipment condition and operator practices.
Similarly, repeated documentation incidents may indicate that procedures or training need improvement.
Trending therefore helps a pharmaceutical company move from reactive problem-solving toward preventive quality management.
Incident Management and GMP in Nepal
Pharmaceutical manufacturers in Nepal operate under the regulatory framework of the Department of Drug Administration (DDA), Nepal.
The DDA provides regulatory information and guidance related to medicines, pharmaceutical manufacturing, quality and regulatory activities.
The World Health Organization also emphasizes the importance of Good Manufacturing Practices in ensuring that pharmaceutical products are consistently produced and controlled according to appropriate quality standards.
The DDA has published guidance on risk-based post-marketing quality surveillance of medicines in Nepal, reflecting the importance of systematic quality monitoring.
For Nepalese pharmaceutical professionals, knowledge of incident investigation is useful alongside subjects such as deviation management, OOS investigation, CAPA, validation and data integrity.
Incident, Deviation, OOS and CAPA
These terms are connected but have different meanings.
Incident: An unexpected event that requires assessment.
Deviation: An unplanned departure from an approved procedure, process, specification or requirement.
OOS: A test result that does not meet an approved specification or acceptance criterion.
CAPA: Corrective and preventive action used to address identified problems and reduce the chance of recurrence.
For example:
Unexpected equipment failure → Incident → Investigation → Impact assessment → Possible deviation → Corrective action or CAPA
The exact classification should always follow the organization's approved procedures.
Final Thoughts
Incidents can happen even in a well-controlled pharmaceutical environment. What matters is how the company responds.
A strong incident-management system encourages employees to report unexpected events, control potential risks, preserve evidence, investigate the underlying cause and take appropriate corrective action.
For QC and QA professionals in Nepal, understanding these principles can make daily pharmaceutical work more systematic and reliable.
An incident should not be viewed simply as a mistake made by an employee. It can also provide valuable information about weaknesses in equipment, procedures, training, maintenance or other parts of the quality system.
When incidents are properly investigated and lessons are applied, they can become opportunities for continuous improvement and stronger pharmaceutical quality.
References
-
World Health Organization (WHO). Good Manufacturing Practices for pharmaceutical products. WHO Quality Assurance of Pharmaceuticals.
-
World Health Organization (WHO). Good Manufacturing Practices (GMP). WHO Health Products Policy and Standards.
-
Department of Drug Administration (DDA), Nepal. Guidelines for Risk-Based Post-Marketing Quality Surveillance of Medicines in Nepal-2080.
-
Department of Drug Administration (DDA), Nepal. Regulatory information and guidance for medicines and pharmaceutical products.
Disclaimer
This article is provided for educational purposes. The Nepal-related examples are hypothetical and are not intended to describe or accuse any particular pharmaceutical company. Pharmaceutical professionals should follow their organization's approved SOPs, quality-management system, applicable GMP requirements and regulatory requirements.
